Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Foie » Cirrhose du foie 07. Mai 2016
Recherche
Gastroplattform
Cirrhose du foie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 1086  Page précédente Page suivante
   
   Articles 1 - 20 / 21703  
   
A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis.
Am J Ther
Silveira MG, Gossard AA, Stahler AC, Jorgensen RA, Petz JL, Ali AH, Lindor KD.
PMID: 27148676 [PubMed - as supplied by publisher]


Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.
BMJ Open
Li T, Ke W, Sun P, Chen X, Belgaumkar A, Huang Y, Xian W, Li J, Zheng Q.
PMID: 27147389 [PubMed - in process]


Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
Sci Rep
Li H, Chen LY, Zhang NN, Li ST, Zeng B, Pavesi M, Amorós À, Mookerjee RP, Xia Q, Xue F, Ma X, Hua J, Sheng L, Qiu DK, Xie Q, Foster GR, Dusheiko G, Moreau R, Gines P, Arroyo V, Jalan R.
PMID: 27146801 [PubMed - in process]


Predictors of fifty days in-hospital mortality in decompensated cirrhosis patients with spontaneous bacterial peritonitis.
World J Hepatol
Bal CK, Daman R, Bhatia V.
PMID: 27134704 [PubMed]


Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?
Turk J Gastroenterol
Y, Akdo, Suna N, Özta, Kuzu UB, Bilge Z, Ayd, Ta.
PMID: 27124284 [PubMed - as supplied by publisher]


The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study.
Liver Int
Jepsen P, Lash TL, Vilstrup H.
PMID: 27124269 [PubMed - as supplied by publisher]


COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL.
Arq Bras Cir Dig
Freitas AC, Shiguihara RS, Monteiro RT, Pazeto TL, Coelho JC.
PMID: 27120734 [PubMed - in process]


Quality of Care in the Cirrhotic Patient.
Clin Transl Gastroenterol
Volk ML, Kanwal F.
PMID: 27101005 [PubMed]


The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Medicine (Baltimore)
Li Q, Song J, Huang Y, Li X, Zhuo Q, Li W, Chen C, Lu C, Qi X, Chen L.
PMID: 27100421 [PubMed - in process]


Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
Eur J Gastroenterol Hepatol
Salman TA, Edrees AM, El-Said HH, El-Abd OL, El-Azab GI.
PMID: 27097354 [PubMed - as supplied by publisher]


Diagnosing and treating renal disease in cirrhotic patients.
Minerva Gastroenterol Dietol
Wong F.
PMID: 27096702 [PubMed - as supplied by publisher]


Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year population-based study.
Aliment Pharmacol Ther
Nilsson E, Anderson H, Sargenti K, Lindgren S, Prytz H.
PMID: 27091240 [PubMed - as supplied by publisher]


Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis.
Radiology
Smith AD, Branch CR, Zand K, Subramony C, Zhang H, Thaggard K, Hosch R, Bryan J, Vasanji A, Griswold M, Zhang X.
PMID: 27089026 [PubMed - as supplied by publisher]


Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Cochrane Database Syst Rev
Gluud LL, Vilstrup H, Morgan MY.
PMID: 27089005 [PubMed - in process]


Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis.
Aliment Pharmacol Ther
Majumdar A, Kitson MT, Roberts SK.
PMID: 27087015 [PubMed - as supplied by publisher]


Rates of and Reasons for Hospital Readmissions in Patients with Cirrhosis: A Multistate Population-based Cohort Study.
Clin Gastroenterol Hepatol
Tapper EB, Halbert B, Mellinger J.
PMID: 27085758 [PubMed - as supplied by publisher]


Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
Radiology
Huang B, Wu L, Lu XY, Xu F, Liu CF, Shen WF, Jia NY, Cheng HY, Yang YF, Shen F.
PMID: 27077381 [PubMed - as supplied by publisher]


Management of portal vein thrombosis in cirrhosis: an update.
Eur J Gastroenterol Hepatol
Mancuso A.
PMID: 27075588 [PubMed - as supplied by publisher]


Laparoscopic Splenectomy and Esophagogastric Devascularization for Liver Cirrhosis and Portal Hypertension Is a Safe, Effective, and Minimally Invasive Operation.
J Laparoendosc Adv Surg Tech A
Yu H, Guo S, Wang L, Dong Y, Tian G, Mu S, Zhang H, Li D, Zhao S.
PMID: 27064936 [PubMed - as supplied by publisher]


The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis.
Aliment Pharmacol Ther
Sandahl TD, McGrail R, Møller HJ, Reverter E, Møller S, Turon F, Hernández-Gea V, Bendtsen F, Vilstrup H, Garcia-Pagan JC, Grønbaek H.
PMID: 27061098 [PubMed - in process]


   
   Articles 1 - 20 / 21703    Page 1 de 1086  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1